TIAA CREF Investment Management LLC trimmed its stake in Monsanto (NYSE:MON) by 51.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,184,992 shares of the basic materials company’s stock after selling 1,269,411 shares during the quarter. TIAA CREF Investment Management LLC owned 0.27% of Monsanto worth $138,383,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently bought and sold shares of MON. Gradient Investments LLC purchased a new stake in shares of Monsanto in the fourth quarter worth approximately $108,000. Americafirst Capital Management LLC bought a new position in Monsanto during the third quarter valued at approximately $148,000. Truewealth LLC bought a new position in Monsanto during the fourth quarter valued at approximately $163,000. McKinley Carter Wealth Services Inc. bought a new position in Monsanto during the fourth quarter valued at approximately $218,000. Finally, Bedel Financial Consulting Inc. bought a new position in Monsanto during the fourth quarter valued at approximately $244,000. 76.25% of the stock is owned by institutional investors and hedge funds.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares in the company, valued at $6,772,277.05. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.79% of the company’s stock.
Monsanto (NYSE MON) opened at $117.77 on Friday. Monsanto has a twelve month low of $111.92 and a twelve month high of $124.20. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $51,661.86, a P/E ratio of 21.73, a price-to-earnings-growth ratio of 1.68 and a beta of 0.95.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same quarter last year, the business earned $0.21 EPS. The company’s revenue for the quarter was up .3% on a year-over-year basis. equities research analysts forecast that Monsanto will post 5.76 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be issued a dividend of $0.54 per share. The ex-dividend date is Thursday, April 5th. This represents a $2.16 annualized dividend and a yield of 1.83%. Monsanto’s dividend payout ratio (DPR) is presently 39.85%.
MON has been the topic of several recent research reports. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Wells Fargo reaffirmed a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Finally, Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $127.30.
TRADEMARK VIOLATION WARNING: “Monsanto (MON) Shares Sold by TIAA CREF Investment Management LLC” was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.thelincolnianonline.com/2018/03/17/monsanto-mon-shares-sold-by-tiaa-cref-investment-management-llc.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.